Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)

SHA:605177 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,570	2,218	3,008	2,274	3,140	4,033
Market Cap Growth	17.05%	-26.27%	32.27%	-27.57%	-22.14%	-
Enterprise Value	3,184	2,681	2,732	1,902	2,504	3,866
Last Close Price	22.83	19.70	26.08	19.48	26.64	33.87
PE Ratio	-	-	24.81	21.78	45.84	35.23
Forward PE	-	10.15	18.20	-	-	-
PS Ratio	3.09	1.85	2.22	1.93	4.41	4.57
PB Ratio	1.42	1.18	1.49	1.24	1.79	2.33
P/TBV Ratio	1.47	1.22	1.54	1.28	1.83	2.40
P/FCF Ratio	-	-	-	-	-	46.99
P/OCF Ratio	-	-	-	-	-	27.45
EV/Sales Ratio	3.83	2.24	2.01	1.61	3.52	4.39
EV/EBITDA Ratio	-	123.59	12.41	10.53	24.56	21.55
EV/EBIT Ratio	-	-	24.43	21.49	76.37	33.21
EV/FCF Ratio	-7.76	-	-	-	-	45.05
Debt / Equity Ratio	0.55	0.42	0.35	0.07	0.00	0.01
Debt / EBITDA Ratio	-	30.46	3.15	0.67	0.02	0.06
Debt / FCF Ratio	-	-	-	-	-	0.12
Asset Turnover	0.24	0.35	0.47	0.50	0.33	0.55
Inventory Turnover	1.04	1.50	1.83	2.03	1.52	2.11
Quick Ratio	0.64	0.82	1.58	1.22	1.64	3.52
Current Ratio	1.66	1.67	2.50	2.09	2.61	4.41
Return on Equity (ROE)	-11.39%	-5.18%	6.29%	5.80%	3.93%	8.88%
Return on Assets (ROA)	-3.76%	-1.99%	2.40%	2.34%	0.95%	4.56%
Return on Invested Capital (ROIC)	-8.70%	-5.58%	6.17%	6.21%	3.06%	13.79%
Return on Capital Employed (ROCE)	-7.90%	-4.20%	4.20%	4.70%	1.80%	6.60%
Earnings Yield	-8.49%	-4.54%	4.03%	4.59%	2.18%	2.84%
FCF Yield	-15.97%	-16.60%	-10.36%	-6.96%	-4.64%	2.13%
Dividend Yield	-	-	1.25%	1.49%	0.75%	1.03%
Payout Ratio	-	-	29.90%	22.37%	57.00%	16.11%
Buyback Yield / Dilution	21.23%	10.52%	-10.13%	0.57%	-30.62%	-2.79%
Total Shareholder Return	21.23%	10.52%	-8.87%	2.06%	-29.87%	-1.76%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.